Old Web
English
Sign In
Acemap
>
authorDetail
>
J. Parra Gonzalez
J. Parra Gonzalez
Medicine
Inactivated vaccine
Natalizumab
Teriflunomide
Glatiramer acetate
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Anti-CD20 disease modifying therapies decrease the humoral response to COVID-19 mRNA vaccination in patients with multiple sclerosis
2021
Multiple Sclerosis Journal
A. Wolf
R.W. Pratt
K. Crooks
T Borko
J. Parra Gonzalez
Timothy Vollmer
A Frazer-Abel
E Escudero Álvarez
Show All
Source
Cite
Save
Citations (0)
Vaccine against SARS-CoV2-generated Immunity in Ocrelizumab-treated Patients: Longitudinal Assessments (VIOLA): Study design and early results
2021
Multiple Sclerosis Journal
Ilya Kister
A. Piquet
Y. Patskovsky
I. Voloshyna
N. Ferstler
R. Curtin
V. Yogambigai
S. Nyovanie
Zoe Rimler
K. Perdomo
T Borko
S. Selva
J. Parra Gonzalez
Tamar Bacon
L. Zhovtis Ryerson
C. Raposo
J Priest
R. Winger
G J Silverman
M. Krogsgaard
Show All
Source
Cite
Save
Citations (0)
1
map